The value of this test, that measures through computer analysis the activity of 70 genes using a sample of tissue removed from a breast tumor, is that doctors and patients can better determine course of treatments.
MammoPrint offers two results -- high risk and low risk -- and accurately picked in studies which women were at low risk at least 90 percent of the time. However, for women who were told they were at high risk for recurrence as a result of the test, just 23 percent experienced a relapse.
"You can't go all the way to the bank with this test," says FDA official Dr. Steven Gutman who argues the test is still better than having no information at all.
Agendia, the Dutch maker of MammoPrint, is exploring ways to make this one-of-a-kind product available in the United States. It has been used in the Netherlands since 2005.
"This test has enormous implications for the short-term future of cancer research in general, and is one of the truly great breakthroughs of our time," says Cancer Blog reader Gregory Pawelski with whom I am grateful for sharing this story tip with me.


Now that Farrah Fawcett has successfully completed treatment for cancer, she is turning her attention to raising money for cancer research and cure.
Earlier this month, Farrah Fawcett successfully completed six weeks of treatment for anal cancer and is reported to be doing very well. According to her publicist Mike Pingel, "The outlook is really good and her spirits are high."
In previous
Paul McCartney lost both his mother Mary and his first wife Linda to breast cancer. Heather Mills McCartney, his current wife, is an 







